Strategic Collaboration with Commonwealth Medical Association

Published 2026-10-09

International agreement aims to advance medical education, professional certification, and scientific collaboration across Commonwealth countries.

London, United Kingdom — October 2026 — The American Board of Regenerative Medicine (ABRM) and the American Board of Longevity Medicine (ABLM) have entered into a strategic academic collaboration with the Commonwealth Medical Association (CMA), marking an important step toward expanding international education and professional development in Regenerative Medicine and Longevity Medicine.

The collaboration was formalized in conjunction with the Global Summit on Longevity and Regenerative Medicine, held on October 1, 2026, in London, United Kingdom.

The Commonwealth Medical Association is an international professional medical organization dedicated to strengthening National Medical Associations and advancing healthcare cooperation across Commonwealth countries.

Under the Memorandum of Understanding, CMA, ABRM, and ABLM will collaborate to promote evidence-based medical education, professional competency development, scientific exchange, and international institutional cooperation.

The agreement establishes a framework for several initiatives, including:

• Expanding awareness and accessibility of ABRM and ABLM educational and professional certification programs.

• Facilitating collaboration with National Medical Associations, universities, teaching hospitals, and healthcare institutions.

• Supporting international conferences, scientific meetings, webinars, and continuing medical education activities.

• Exploring opportunities for authorized educational affiliates, training centers, and examination centers.

• Advancing professional education in Regenerative Medicine, Longevity Medicine, preventive medicine, and healthy aging.